1. Clinical Overview
A potent topical quadruple combination therapy primarily used for severe, infected, inflammatory dermatoses, particularly those complicated by fungal and bacterial infections. It combines a broad-spectrum antiseptic (Chlorhexidine), a super-potent topical corticosteroid (Clobetasol), an imidazole antifungal (Miconazole), and an aminoglycoside antibiotic (Neomycin). This formulation is designed for short-term management of acute flare-ups where infection is present or suspected, commonly used in the Indian context for conditions like infected eczema, severe intertrigo, and infected psoriasis.
| Onset | Duration | Bioavailability |
|---|---|---|
| Clobetasol: Anti-inflammatory and antipruritic effects begin within 1-3 hours. Miconazole: Fungistatic action begins within 24-48 hours. Neomycin: Bactericidal action begins within hours. Chlorhexidine: Immediate antiseptic action. | Clobetasol: Effects can last 12-24 hours after application, necessitating 1-2 times daily application. The overall therapeutic duration for the combination is typically 1-2 weeks, as per the super-potent steroid's safety profile. | Topical; systemic absorption is generally low but can be significant if applied to large areas, broken skin, under occlusion, or on thin-skinned areas. Clobetasol: <5% systemic absorption from intact skin, higher from inflamed skin. Neomycin: <1% absorbed. Miconazole: Negligible systemic absorption. Chlorhexidine: Minimal percutaneous absorption. |
2. Mechanism of Action
This combination exerts a multifaceted action: 1) Chlorhexidine disrupts microbial cell membranes, providing broad-spectrum antiseptic cover. 2) Clobetasol, a super-potent glucocorticoid, binds to intracellular receptors, inhibiting phospholipase A2, thereby reducing the synthesis of pro-inflammatory mediators (prostaglandins, leukotrienes) and causing vasoconstriction, immune cell suppression, and antipruritic effects. 3) Miconazole inhibits fungal ergosterol synthesis by blocking 14-alpha-demethylase, damaging the fungal cell membrane. 4) Neomycin, a bactericidal aminoglycoside, binds to the 30S ribosomal subunit, inhibiting bacterial protein synthesis.
3. Indications & Uses
- Severe eczema (atopic dermatitis) with secondary bacterial and/or fungal infection
- Infected psoriasis plaques
- Severe intertrigo (inflammatory rash in skin folds) with candidal and bacterial superinfection
- Infected lichen simplex chronicus
- Severe contact dermatitis with evidence of infection
4. Dosage & Administration
Adult Dosage: Apply a thin film to the affected area once or twice daily, as directed by the physician. Typical duration is 1 to 2 weeks maximum. Do not exceed 50 grams per week.
Administration: 1. Wash and dry the affected area gently. 2. Apply a thin layer and rub in lightly until it disappears. 3. Wash hands after application unless hands are being treated. 4. Do not cover with airtight dressings (occlusion) unless specifically advised by a doctor, as this drastically increases absorption and side effects. 5. Do not apply to broken or ulcerated skin unless specifically indicated for infection.
5. Side Effects
Common side effects may include:
- Local burning or stinging sensation (usually transient)
- Itching (pruritus) at application site
- Dryness of skin
- Erythema (redness)
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Other Topical Corticosteroids | Additive risk of skin atrophy and systemic side effects. | Major |
| Other Aminoglycosides (e.g., Gentamicin, systemic) | Increased risk of nephrotoxicity and ototoxicity if neomycin is systemically absorbed. | Major |
| Diuretics (e.g., Furosemide) | Increased risk of ototoxicity with neomycin. | Moderate |
| Neuromuscular Blocking Agents | Neomycin may potentiate neuromuscular blockade. | Moderate |
| CYP3A4 Inhibitors (e.g., Ketoconazole, Itraconazole, Clarithromycin) | May increase systemic levels of Clobetasol by inhibiting its metabolism, increasing steroid side effects. | Moderate |
7. Patient Counselling
- DO use exactly as prescribed by your doctor.
- DO apply a thin layer only.
- DO wash hands before and after application (unless treating hands).
- DO report any lack of improvement or worsening after 3-4 days.
- DON'T use on the face, underarms, or groin unless specifically instructed.
- DON'T cover the area with bandages or plastic wraps unless told to do so.
- DON'T use for longer than the prescribed duration (usually 1-2 weeks).
- DON'T share this medicine with others.
8. Toxicology & Storage
Overdose: Topical overdose: Exaggerated local side effects - severe skin atrophy, striae, ulceration, HPA axis suppression symptoms (fatigue, anorexia, nausea, dizziness, hypotension). Systemic neomycin toxicity from massive topical application: ototoxicity (hearing loss, tinnitus), nephrotoxicity (increased creatinine).
Storage: Store at room temperature (15-25°C), protected from light and moisture. Do not freeze. Keep the tube tightly closed. Keep out of reach and sight of children. Do not use after the expiry date printed on the pack.